STAAR SURGICAL CO — Director's Dealing 2022

May 21, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2022-05-18

Reporting Person: Mason Caren L (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-18	Common Stock	M	35000	$9.30	Acquired	118645	Direct
2022-05-18	Common Stock	S	35000	$56.46	Disposed	83645	Direct
2022-05-19	Common Stock	M	35000	$9.30	Acquired	118645	Direct
2022-05-19	Common Stock	S	35000	$57.49	Disposed	83645	Direct
2022-05-20	Common Stock	M	35000	$9.30	Acquired	118645	Direct
2022-05-20	Common Stock	S	35000	$58.48	Disposed	83645	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-18	Common Stock Options	$9.30	M	35000	Acquired	2027-03-20	Common Stock (35000)	Direct
2022-05-19	Common Stock Options	$9.30	M	35000	Acquired	2027-03-20	Common Stock (35000)	Direct
2022-05-20	Common Stock Options	$9.30	M	35000	Acquired	2027-03-20	Common Stock (35000)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.43 to $57.97.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.89 to $58.15.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.16 to $60.62.